Treatment of subclinical hypothyroidism in pregnancy using fixed thyroxine daily doses of 75 μg

Background and objectives: Treatment of hypothyroid pregnant women is usually calculated based on weight (1 g/kg/day) and TSH levels. This study assessed the usefulness of treating these women with a fixed dose of 75 g/day. Patients and methods: All women with pregnancy diagnosed from January to August 2012 in the Vigo Health Area (Spain) without previous diagnosis of thyroid disease or thyroxine treatment and with TSH levels over 4.5 mUl/mL were enrolled by consecutive sampling. All 116 women in the sample were treated with a fixed daily dose of thyroxine 75 mu g-thyroxine levels were measured at two, four, and six months, and thyroxine dose was modified if TSH level was lower than 0.3 or higher than 4.5 mUl/mL. Results: A woman had a TSH level less than 0.3 mUl /mL in a test; reduction of thyroxine dose to 5014/day allowed for maintaining TSH level within the desired range until delivery. Six women had TSH levels over 4.5 mUI/mL in one test; in all of them, increase in thyroxine dose to 100 rig/day allowed for maintaining the level within the desired range until delivery. Conclusions: Fixed daily doses of thyroxine 7514 allowed for achieving goal TSH levels in most of our pregnant women with subclinical hypothyroidism, irrespective of their weight and baseline TSH level. (C) 2013 SEEN. Published by Elsevier Espana, S.L. All rights reserved.